Amyloid PET has become a pivotal imaging biomarker for Alzheimer disease (AD), enabling in vivo detection and quantification ...

PET scans can detect amyloid plaques and tau tangles in the brain, which are often early signs of Alzheimer’s disease. But they’re not enough on their own to make a diagnosis. Alzheimer’s disease is ...

New criteria could lead to a diagnosis on the basis of a simple blood test, even in the absence of obvious symptoms. By Paula Span Determining whether someone has Alzheimer’s disease usually requires ...

Please provide your email address to receive an email when new articles are posted on . C 2 N Diagnostics released the PrecivityAD2 blood test, which uses positron emission tomography scans and ...

Emory researchers discovered blood changes that could allow Alzheimer’s to be detected years before symptoms appear. The team is developing a blood test that may identify early risk and guide ...

In an oral presentation at the 2025 AAN Annual Meeting, Quest scientists presented data suggesting the test can accurately assess Alzheimer's disease pathology with greater than 90% sensitivity and ...

A new generation of blood tests is poised to change the way doctors determine whether patients with memory loss also have Alzheimer's disease. The tests detect substances in the blood that indicate ...

Alzheimer’s disease blood test developer C2N Diagnostics has released a new version of its screener for beta amyloid proteins, and it’s gearing up for a nationwide rollout as public hopes rise for ...

On the heels of hopeful clinical trial results for a drug that may work against Alzheimer’s, Japanese regulators have approved a simple blood test to identify potential patients with the hallmark ...